Discontinued — last reported Q2 '18
Thermo Fisher Scientific Fair Value Measurement Disclosure increased by 10.2% to $65.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 150.0%, from $26.00M to $65.00M.
Higher levels indicate a larger portion of the balance sheet is subject to market-based valuation volatility.
This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring o...
Standard disclosure for financial institutions with significant investment holdings.
fair_value_measurement_disclosure| Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $26.00M | $21.00M | $31.00M | $59.00M | $65.00M |
| QoQ Change | — | — | — | -19.2% | +47.6% | +90.3% | +10.2% |
| YoY Change | — | — | — | — | — | — | +150.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.